Current issues in immunisation (The Measles Control Campaign and immunisation adverse events)
DOI:
https://doi.org/10.33321/cdi.1998.22.31Keywords:
measles control, adverse event following immunisation, measles-mumps-rubella vaccineAbstract
This article discusses the importance of the recently launched Measles Control Campaign, balanced against an expected temporary increase in reports of adverse events following vaccination.
Downloads
References
Peltola H, Heinonen OP. Frequency of true adverse reactions to measles-mumps-rubella vaccine: a double-blind placebo-controlled trial in twins. Lancet 1986;1:939-942.
Farrington P, Pugh S, Colville A, et al. A new method for active surveillance of adverse events from diphtheria-tetanus-pertussis and measles/mumps/rubella vaccines. Lancet 1995;345:567-569.
Stratton KR, Howe CJ, Johnston RB, editors. Adverse events associated with childhood vaccines. Evidence based on causality. Washington, DC: National Academy Press, 1994.
Howson CP, Fineberg HV. Adverse events following pertussis and rubella vaccines. Summary of a report of the Institute of Medicine. JAMA 1992;267:392-396.
Stratton KR, Howe CJ, Johnston RBJr. Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine. JAMA 1994;271:1602-1605.
Tingle AJ, Allen M, Petty RE, Kettyls GD, Chantler KJ. Rubella-associated arthritis. 1. Comparative study of joint manifestations associated with natural rubella infection and RA27/3 rubella immunisation. Ann Rheum Dis 1986;45:110-114.
Tingle AJ, Mitchell LA, Grace M, et al. Randomised double-blind placebo-controlled study on adverse effects of rubella immunisation in seronegative women. Lancet 1997;349:1277-1281.
Ray P, Black S, Shinefield H, et al. Risk of chronic arthropathy among women after rubella vaccination. Vaccine Safety Datalink Team. JAMA 1997;278:551-556.
Slater PE. Chronic arthropathy after rubella vaccination in women. False alarm? [Editorial] JAMA 1997;278:594-595.
Weibel RE, Caserta V, Benor DE, Evans G. Acute encephalopathy followed by permanent brain injury or death with further attenuated measles vaccines: a review of claims submitted to the National Vaccine Injury Compensation Program. Pediatrics 1998;101:383-387.
National Health and Medical Research Council. The Australian immunisation handbook, 6th edition. Watson C, editor. Canberra: AGPS, 1997. ISBN 0644 47578 1.
Amin J, McIntyre PB, Heath TC. Measles vaccine, inflammatory bowel disease and pervasive development disorder: is there a cause for concern? Commun Dis Intell 1998;22:58-59.
McIntyre PB, O'Brien ED, Heath TC. Immunisation and asthma. Commun Dis Intell 1998;22:38.
King GE, Markowitz LE, Heath J, et al. Antibody response to measles-mumps-rubella vaccine of children with mild illness at the time of vaccination. JAMA 1996;275:704-707.
Cutts F. Revaccination against measles and rubella [editorial comment]. BMJ 1996;312:589-590.
Communicable Diseases Surveillance Centre. The national measles and rubella campaign - one year on. Comm Dis Rep 1995;5:237.
Salisbury DM, Campbell H, Edwards B. Measles rubella immunisation campaign in England. One year on [departmental report]. London: Department of Health, November 1995.
Dobson S, Scheifele D, Bell A. Assessment of a universal, school-based hepatitis B vaccination program. JAMA 1995;274:1209-1213.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 1998 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
